Company intelligence / Profile preview

Biorelate

Manchester, England, United Kingdombiorelate.com ↗

Ownership: Private
Development stage: Other

Overview

Biorelate’s Galactic AI™ platform curates biomedical literature using advanced artificial intelligence and natural language processing to build comprehensive knowledge graphs. It accelerates target selection, mechanism-of-action elucidation, biomarker discovery, and indication expansion for biopharma R&D. The technology has processed over 43 million documents with more than three billion cause-and-effect interaction mentions contextualized for decision-making by leading pharmaceutical companies such as Pfizer and AstraZeneca. No clinical results as the company does not develop drugs itself.

Modalities: Small moleculeMonoclonal antibodyCell therapyGene therapy
Industry: Drug Discovery Services

Partnerships

PfizerAstraZenecaTurbinePepper BioIdorsia Pharmaceuticalse-TherapeuticsApconixAstex Pharmaceuticals

Beyond the preview

Go deeper on Biorelate.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Biorelate.

Explore the full profile